Hey Boys, good to hear from some old friends, don't see milman around anymore, hope he is doing well and hope both of you are enjoying life and staying healthy. This has taken a nosedive, but what else is new. Where are my Celly shares, was supposed to have them months ago? Did some digging, there is a meeting on the 22nd and if I read point number 4 correctly, what another 100:1 split? Oh my. Item 5 is a name change and we all know the reasoning behind that.
Enjoy the summer and stay safe boys!!!
1. to receive and consider the audited consolidated annual financial statements of the Company for the financial years ended December 31, 2023 and 2022, together with the reports of the auditor thereon (the “Financial Statements”);
2. to elect directorsto the board of directors oftheCompany (the “Board”)forthe ensuing year, as more particularly set forth in the accompanying management information circular dated July 10, 2024, and prepared for the purpose of the Meeting (the “Circular”);
3. to re-appoint MNP LLP as the auditor of the Company for the ensuing year and to authorize the Board to fix the remuneration of the auditor, as more particularly set forth in the Circular;
4. to consider and, if deemed advisable, to pass with or without variation, a special resolution providing for the consolidation of the Company’s issued and outstanding class A multiple voting shares (the “MVS”) and class B subordinate voting shares (the “Class B Subordinate Voting Shares”) at such a consolidation ratio to be determined by the Board, in its sole discretion, at such a consolidation ratio, of up to one hundred (100) pre-consolidation MVS and Class B Subordinate Voting Shares for one (1) post-consolidation MVS and Class B Subordinate Voting Shares;
5. to consider and, if deemed advisable, to pass, with or without variation, a special resolution approving a change in the name of the Company to be such name as determined by the Board in its sole discretion;
6. the holders of Class B Subordinate Voting Shares, exclusive of Class B Subordinate Voting Shares held by holders of MVS, will be asked to consider and, if deemed advisable, to pass, with or without variation, a special resolution approving and ratifying the Company’s articles of amendment which were filed on February 3, 2020, expanding the definition of “Permitted Holders” under the Company’s articles, as further described in the Circular;
7. the holders of Class B Subordinate Voting Shares, exclusive of Class B Subordinate Voting Sharesheld by holders of MVS, will be asked to consider and, if deemed advisable, to pass, with or without variation, an ordinary resolution authorizing the Board to approve, in its sole discretion, the issuance of additional MVS up to the maximum number permitted by the applicable regulatory authorities, as further described in the Circular; and
8. to transact such further and other business as may properly be brought before the Meeting or any adjournment(s) thereof.
RE:RE:RE:New Press Release - FSD Pharma provides Corporate Update